DE60212425D1 - Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln - Google Patents

Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln

Info

Publication number
DE60212425D1
DE60212425D1 DE60212425T DE60212425T DE60212425D1 DE 60212425 D1 DE60212425 D1 DE 60212425D1 DE 60212425 T DE60212425 T DE 60212425T DE 60212425 T DE60212425 T DE 60212425T DE 60212425 D1 DE60212425 D1 DE 60212425D1
Authority
DE
Germany
Prior art keywords
medicaments
preparation
high sialylation
sialylation rate
fsh compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60212425T
Other languages
English (en)
Other versions
DE60212425T2 (de
Inventor
Ernest Loumaye
Carlo Emanuele Giartosio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23323355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60212425(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Publication of DE60212425D1 publication Critical patent/DE60212425D1/de
Application granted granted Critical
Publication of DE60212425T2 publication Critical patent/DE60212425T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
DE60212425T 2001-10-22 2002-10-15 Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln Revoked DE60212425T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33808801P 2001-10-22 2001-10-22
US338088P 2001-10-22
PCT/EP2002/011501 WO2003035686A2 (en) 2001-10-22 2002-10-15 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments

Publications (2)

Publication Number Publication Date
DE60212425D1 true DE60212425D1 (de) 2006-07-27
DE60212425T2 DE60212425T2 (de) 2006-11-09

Family

ID=23323355

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212425T Revoked DE60212425T2 (de) 2001-10-22 2002-10-15 Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln

Country Status (24)

Country Link
US (1) US20050085412A1 (de)
EP (2) EP1438336B1 (de)
JP (1) JP2005515974A (de)
KR (1) KR100929971B1 (de)
CN (1) CN1608078B (de)
AR (1) AR036926A1 (de)
AT (1) ATE329930T1 (de)
AU (1) AU2002340562B2 (de)
CA (1) CA2464368A1 (de)
DE (1) DE60212425T2 (de)
DK (1) DK1438336T3 (de)
EA (1) EA007030B1 (de)
ES (1) ES2261740T3 (de)
HR (1) HRP20040278B1 (de)
IL (2) IL161235A0 (de)
ME (1) MEP38608A (de)
MX (1) MXPA04003352A (de)
NO (1) NO327966B1 (de)
PL (1) PL369606A1 (de)
PT (1) PT1438336E (de)
RS (1) RS32804A (de)
UA (1) UA87433C2 (de)
WO (1) WO2003035686A2 (de)
ZA (1) ZA200402279B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
ES2620261T3 (es) * 2006-09-10 2017-06-28 Glycotope Gmbh Uso de células humanas de origen leucémico mieloide para expresión de anticuerpos
CN101264096B (zh) * 2007-03-12 2011-11-09 中国医学科学院药物研究所 人参皂苷Rg1在制备生精产品中的应用
US8742079B2 (en) 2007-08-20 2014-06-03 Protalix Ltd. Saccharide-containing protein conjugates and uses thereof
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
AU2010238758A1 (en) * 2009-04-22 2011-12-15 The Regents Of The University Of California In vivo 1H magnetic resonance spectroscopy for the diagnosis of testicular function and disease
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
CN102464713A (zh) * 2010-12-21 2012-05-23 上海丽珠制药有限公司 一种卵泡刺激素的制备方法
DK2665814T3 (en) 2011-01-20 2017-09-11 Protalix Ltd NUCLEIC ACID CONSTRUCTION FOR EXPRESSION OF ALPHA-GALACTOSIDASE IN PLANTS AND PLANT CELLS
JP6087338B2 (ja) 2011-03-31 2017-03-01 フェリング ベスローテン フェンノートシャップ 医薬製剤
EP2717904A1 (de) * 2011-06-06 2014-04-16 Ferring BV Pharmazeutische zubereitung mit rekombinantem fsh
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
JP2017513853A (ja) 2014-04-18 2017-06-01 グリコトープ ゲーエムベーハー 改良された組換えヒト卵胞刺激ホルモンを用いた制御された卵巣過剰刺激
DK3794042T3 (da) 2018-05-18 2024-04-15 Daiichi Sankyo Co Ltd Anti-muc1-exatecet-antistof-lægemiddelkonjugat

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1057895B (it) * 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5541083A (en) * 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
US5834251A (en) * 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
IL130964A0 (en) * 1997-01-16 2001-01-28 Cytel Corp Practical in vitro sialylation of recombinant glycoproteins
JP4511042B2 (ja) * 1998-08-07 2010-07-28 メルク セローノ ソシエテ アノニム 不妊症の治療のためのｆｓｈ模倣物
CA2348430A1 (en) * 1998-10-28 2000-05-04 Baylor College Of Medicine Ovary-specific genes and proteins
EP1171615B1 (de) * 1999-04-26 2006-12-13 Genentech, Inc. Zellenzuchtverfahren für glycoproteine
JP2001299362A (ja) * 1999-12-17 2001-10-30 Takeda Chem Ind Ltd 新規ポリペプチドおよびそのｄｎａ
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones

Also Published As

Publication number Publication date
CN1608078A (zh) 2005-04-20
CA2464368A1 (en) 2003-05-01
EP1621549A2 (de) 2006-02-01
UA87433C2 (ru) 2009-07-27
PL369606A1 (en) 2005-05-02
EA200400574A1 (ru) 2004-08-26
DK1438336T3 (da) 2006-10-02
IL161235A (en) 2009-07-20
HRP20040278B1 (en) 2008-03-31
EP1438336A2 (de) 2004-07-21
ATE329930T1 (de) 2006-07-15
EA007030B1 (ru) 2006-06-30
CN1608078B (zh) 2012-07-25
HRP20040278A2 (en) 2005-04-30
RS32804A (en) 2007-02-05
KR100929971B1 (ko) 2009-12-04
MXPA04003352A (es) 2004-07-08
PT1438336E (pt) 2006-08-31
ES2261740T3 (es) 2006-11-16
NO327966B1 (no) 2009-11-02
WO2003035686A3 (en) 2003-10-09
US20050085412A1 (en) 2005-04-21
JP2005515974A (ja) 2005-06-02
AR036926A1 (es) 2004-10-13
KR20040045885A (ko) 2004-06-02
IL161235A0 (en) 2004-09-27
WO2003035686A2 (en) 2003-05-01
EP1438336B1 (de) 2006-06-14
AU2002340562B2 (en) 2008-10-23
ZA200402279B (en) 2005-10-26
EP1621549A3 (de) 2006-03-01
DE60212425T2 (de) 2006-11-09
NO20042061L (no) 2004-07-13
MEP38608A (en) 2011-02-10

Similar Documents

Publication Publication Date Title
DE60212425D1 (de) Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69832731D1 (de) Arzneimittel mit magensaftresistentem überzug und methode zur herstellung
DE50212302D1 (de) 17alpha-alkyl-17beta-oxy-estratriene und zwischenprodukte zu deren herstellung, verwendung der 17alpha-alkyl-17beta-oxy-estratriene zur herstellung von arzneimitteln sowie pharmazeutische präparate
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
DE60224111D1 (de) Bausatz zur Herstellung einer Verabreichungsform zur Abgabe einer bioaktiven Substanz
HUP0401293A3 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
DE69903515D1 (de) Zusammensetzung zur herstellung von temporären zahnkronen und haltebrücken
DE69908032T2 (de) Oxidverbindung aus Spineltyp und Verfahren zur Herstellung derselben
DE60130834D1 (de) Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
DE60220258D1 (de) Derivate von quinolyl-propyl-piperidine, deren herstellung und die sie enthaltenden zusamensetzungen
DE60131979D1 (de) Beschichtungsmaterial zur herstellung von titaniumoxidfilmen, herstellungsverfahren und nutzung dieses beschichtungsmaterials
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
EP1449860A4 (de) Neues fluorpolymer, dieses enthaltende resistzusammensetzungen und neue fluormonomere
DE50209948D1 (de) Verwendung von Scopinester Derivaten zur Herstellung von Arzneimitteln
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
DE69901243T2 (de) Artikulator zur herstellung von zahnärztlichen prothesen
DE60222806D1 (de) Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DE69821340D1 (de) Polymermischung zur Herstellung von medizinischen Vorrichtungen
PL369632A1 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
DE60208365D1 (de) Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln
SI1438336T1 (sl) Fsh-sestavki z visoko sialilacijsko stopnjo in njihova uporaba pri pripravi zdravil
ATE403642T1 (de) Kristalline form eines phenylethanolamins, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE60143350D1 (de) Verfahren zur herstellung von 1,3-dialkyl-2-imidazolidinon-derivaten
DE50209082D1 (de) Zwischenverbindungen zur herstellung von spinosynen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH

8331 Complete revocation